Hepatic arterial chemotherapy (HAC) with oxaliplatin (OXA), leucovorin (LV) and 5-fluorouracil (5FU): A feasible and effective regimen.

被引：0
|
作者：
Del Freo, DFAA
Lombardi, M
Mambrini, A
Muttini, MP
Pennucci, MC
Sanguinetti, F
Torri, T
Cantore, M
机构：
[1] ASL 01 Massa Carrara, Dept Oncol, Carrara, Italy
[2] ASL 01 Massa Carrara, Dept Surg, Carrara, Italy
[3] ASL Massa Carrara, Dept Oncol, Carrara, Italy
[4] ASL 01 Massa Carrara, Dept Radiol, Carrara, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Anselmi, E
    Bidin, L
    Palladino, M
    Rodinò, C
    ANNALS OF ONCOLOGY, 2005, 16 : 323 - 323
  • [22] Phase II trial of oxaliplatin, 5-fluorouracil (5-FU) and leucovorin (LV) for advanced biliary tract adenocarcinoma.
    Porschen, R
    Nehls, O
    Bermann, A
    Burkart, C
    Gregor, M
    GASTROENTEROLOGY, 1999, 116 (04) : A487 - A487
  • [23] Oxaliplatin with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFOX6)
    Maindrault-Goebel, F
    de Gramont, A
    Louvet, C
    Andre, T
    Carola, E
    Gilles-Amar, V
    Izrael, V
    Krulik, M
    ANNALS OF ONCOLOGY, 1998, 9 : 36 - 36
  • [24] Bi-fractionated oxaliplatin (L-OHP) plus 5-fluorouracil (5FU)/leucovorin (LV) for elderly patients (pts) with advanced colorectal cancer (CRC).
    Massacesi, C
    Lippe, P
    Recchia, F
    Marcucci, F
    Rocchi, M
    Cesta, A
    Pilone, A
    Cappelletti, C
    Bonsignori, M
    Mattioli, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 275S - 275S
  • [25] Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) - A phase II study.
    Tsavdaridis, D
    Athanasiadis, A
    Pissanidis, N
    Saleh, M
    Moshidis, A
    Chatzichristou, A
    Makrantonakis, N
    Kamentsidis, P
    Natsiopoulos, I
    Christakis, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 297S - 297S
  • [26] REGIONAL CHEMOTHERAPY TO THE CANINE LIVER WITH 5-FLUOROURACIL (5FU) AND ADRIAMYCIN (AM)
    KARAKOUSIS, CP
    SHARMA, SD
    KANTER, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 211 - 211
  • [27] Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Gallbladder Cancer
    Zheng, Kanglian
    Wang, Xiaodong
    Cao, Guang
    Xu, Liang
    Zhu, Xu
    Fu, Liqiang
    Fu, Shijie
    Cheng, Haihui
    Yang, Renjie
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (02) : 271 - 280
  • [28] Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Gallbladder Cancer
    Kanglian Zheng
    Xiaodong Wang
    Guang Cao
    Liang Xu
    Xu Zhu
    Liqiang Fu
    Shijie Fu
    Haihui Cheng
    Renjie Yang
    CardioVascular and Interventional Radiology, 2021, 44 : 271 - 280
  • [29] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [30] POTENTIATION OF 5-FLUOROURACIL (5-FU) ANTI-METABOLIC EFFECT BY LEUCOVORIN (LV)
    WAXMAN, S
    BRUCKNER, H
    WAGLE, A
    SCHREIBER, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 149 - 149
12345